Clinical Trial Update: Evaluation of an Oral Contraceptive Containing 30 mg Ethinyloestradiol and 150 mg Desogestrel on Women's Health [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating an oral contraceptive containing ethinylestradiol and desogestrel for women with premenstrual syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premenstrual Syndrome

Drugs mentioned

• Ethinylestradiol/Desogestrel (ethinylestradiol and desogestrel)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Women With PMS | Phase 2 | Status: UNKNOWN